APDS
UK Regulator Approves Pharming’s Joenja for Rare Immune Disorder APDS, Leveraging FDA Review
Joenja, leniolisib, APDS, MHRA approval, FDA review, rare immune disorder, Pharming
Actionable Insights Powered by AI
Joenja, leniolisib, APDS, MHRA approval, FDA review, rare immune disorder, Pharming